Home healthcare market seen topping $708 billion by 2030

The Business Research Company says the global home healthcare market is set to surpass $708 billion by 2030, with Western Europe emerging as the largest regional market. The report points to aging populations, chronic disease growth and faster adoption of remote care technologies as the main drivers.

Why it matters: - Home healthcare is moving from a niche service to a major care delivery channel as patients, providers and insurers look for lower-cost alternatives to hospital care. - The market’s projected scale, regional mix and technology shifts could reshape where companies invest in services, devices and digital health tools.

What happened: - The Business Research Company published its Home Healthcare Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report says the home healthcare market is on track to exceed $708 billion by 2030. - The market is forecast to grow at an 11% compound annual rate through 2030. - Home healthcare is expected to account for nearly 6% of the broader healthcare services market by 2030.

The details: - Therapeutic equipment is projected to be the largest equipment category by 2030, reaching 53% of the market and about $373 billion. - The report links that segment’s growth to long-term respiratory and infusion therapies at home, home-based rehabilitation, chronic disease management and advanced therapeutic devices. - The report also breaks the market into rehabilitation, respiratory therapy, infusion therapy and other services. - By medical indication, the market spans cardiovascular disorders and hypertension, diabetes, respiratory diseases, cancer, wound care and other conditions. - Western Europe is projected to be the largest regional market by 2030 at $261 billion, up from $158 billion in 2025. - Western Europe’s home healthcare market is expected to grow at an 11% CAGR, supported by an aging population, government backing for community healthcare, lower-cost care preferences and more skilled home care professionals. - The U.S. is expected to be the largest single-country market, reaching $193 billion in 2030 from $128 billion in 2025. - The U.S. market is forecast to grow at 9% annually, helped by chronic disease prevalence, expanded reimbursement, remote patient monitoring, virtual care and demand for post-acute and rehabilitative care. - UnitedHealth Group Incorporated was the top global seller in 2025 with a 1% market share. - CVS Health Corporation, Fresenius SE & Co. KGaA and McKesson Corporation each held 1% of the market in 2025. - Amedisys Inc. held 0.4%, AccentCare Inc. and Kindred Healthcare Inc. each held 0.3%, Enhabit, Inc. held 0.2%, and Brookdale Senior Living Inc. and Koninklijke Philips N.V. each held 0.1%. - The 10 largest players held just 4% of total market revenue in 2025, underscoring how fragmented the market remains. - The report identifies aging populations and chronic disease burden as a major growth driver, contributing about 2.2% to annual market growth. - Demand for more affordable care models is expected to add about 1.8% to yearly growth. - Telehealth, connected devices, wearables, digital health apps and AI-powered monitoring are forecast to contribute about 1.5% to annual growth. - The report says therapeutic, diagnostic and mobility care equipment together could add more than $286 billion by 2030. - Within that gain, therapeutic care is projected to rise by $150 billion, diagnostic equipment by $90 billion and mobility care by $46 billion between 2025 and 2030. - The report says AI is already changing home healthcare operations. - In September 2025, Homecare Homebase introduced three AI-driven tools in its HCHB Intelligence Suite to automate referral processing, medication documentation and real-time patient risk insights. - The company says the new report also includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables.

Between the lines: - The market’s fragmentation suggests no single player has dominant control, which leaves room for regional operators, device makers and digital health firms to win share through partnerships and specialized offerings. - Western Europe’s lead indicates that policy support and demographic pressure can matter as much as technology adoption in determining where growth concentrates. - AI and remote monitoring are becoming operational tools, not just care add-ons, which could push providers to invest more in workflow automation and connected care infrastructure.

What's next: - Growth is likely to favor companies that can combine home-based services, remote monitoring and reimbursement-friendly care models. - The fastest expansion should continue in therapeutic devices, diagnostics and mobility care, especially where chronic disease management and post-acute care needs are highest. - Further consolidation is possible, but the report suggests fragmented competition will remain a defining feature in the near term.

The bottom line: - Home healthcare is entering a high-growth phase led by Western Europe, but the real opportunity appears to be in technology-enabled care delivery, not just traditional home visits.